Mike Lawless, CFO, discusses growth expectations for ReWalk, AlterG, and MyoCycles in the 2025 guidance, focusing on profitable growth.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Mike Lawless, CFO, discusses growth expectations for ReWalk, AlterG, and MyoCycles in the 2025 guidance, focusing on profitable growth.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing